相关实验视频

Updated: Jan 8, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

抑制TGF-β信号传递可以防止α-synuclein诱导的毒性

Oscar Wing Ho Chua^1,2, Linghan Duan¹, Svenja Hanna Bothe¹

¹Department of Neurology, Hannover Medical School, Hannover, Germany.

Cell death discovery

|December 12, 2025

概括

研究人员发现,抑制转化生长因子-β (TGFb) 途径可以在帕金森病模型中防止α-synuclein (aSyn) 毒性. 这表明准TGFb信号可能是PD的新治疗策略.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

帕金森病 (PD) 的特征是Lewy体,主要是聚合的α-synuclein (aSyn).
据信,寡合性aSyn中间体会引起神经毒性,导致多巴胺基神经元死亡.
需要新的治疗策略来防止aSyn诱导的细胞死亡.

研究的目的:

研究转化生长因子-β (TGFb) 途径在aSyn诱导的神经毒性的作用.
通过调节TGFb信号传导来确定帕金森病的潜在治疗点.

主要方法:

在aSyn诱导的多巴胺细胞死亡模型中进行全基因组siRNA查.
使用针对TGFb通路基因 (ALK5,SMAD2) 的特定siRNAs进行保护基因淘汰的验证.
评估TGFb连接体对aSyn毒性和SNCA mRNA表达的影响.

主要成果:

破坏TGFb通路基因 (ALK5,SMAD2) 证明了对aSyn毒性的神经保护.
增加TGFb信号加剧了aSyn诱导的毒性,而其抑制减轻了这种影响.
在aSyn-overexpressing细胞中,TGFb配体治疗上调了SNCA mRNA的表达.

结论:

与TGFb通路的干扰显示出对aSyn诱导的毒性进行保护的潜力.
调节TGFb信号传递为开发新的帕金森病疗法提供了一个有希望的途径.
在aSyn-overexpressing细胞中对TGFb通路基因的上调支持向该通路.

更多相关视频

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...